Skip to main content
. 2018 Nov 16;97(46):e13157. doi: 10.1097/MD.0000000000013157

Table 2.

Comparison of relapse rate, drug dose, and drug-free period in patients with childhood-onset, difficult-to-treat nephrotic syndrome.

3.1.